国际皮肤性病学杂志    2006 32 (3): 162-164   ISSN: 2096-5540  CN: 32-1880/R   线状IgA大疱性皮肤病的研究进展 刘苏俊, 冯素英, 林麟 中国医学科学院、中国协和医科大学皮肤病研究所 南京 210042 收稿日期 2005-11-17  修回日期 null  网络版发布日期 null 参考文献  [1] Nanda A,Dvorak R,Al-Saeed K,et al.Spectrum of autoimmune bullous diseases in Kuwait.Int J Dermatol,2004,43:876-881. [2] Egan CA,Zone JJ.Linear IgA bullous dermatosis.Iht J Dermatol,1999,38:818-827. [3] Salmhofer W,Soyer HP,Wolf P,et al.UV light-induced linear IgA dermatosis.J Am Acad Dermatol,2004,50:109-115. [4] Armstrong AW,Fazeli A,Yeh SW,et al.Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme.J Cutan Pathol,2004,31:393-397. [5] Perrett CM,Evans AV,Russell-Jones R.Tea tree oil dermatitis associated with linear IgA disease.Clin Exp Dermatol,2003,28:167-170. [6] Girao L,Fiadeiro T,Rodrigues JC.Burn-induced linear IgA dermatosis.J Eur Acad Dermatol Venereol,2000,14:507-510. [7] Cooke N,Jenkinson H,Wojnarowska F,et al.Coexistence of psoriasis and linear IgA disease in apatient with recent herpes zoster infection.Clin Exp Dermatol,2005,30:643-645. [8] Zone JJ.Clinical spectrum,pathogenesis and treatment of linear IgA bullous dermatosis.J Dermatol,2001,28:651-653. [9] Allen J,Wojnarowska F.Linear IgA disease:the IgA and IgG response to the epidermal antigens demonstrates that intermolecular epitope spreading is associated with IgA rather than IgG antibodies,and is more common in adults.Br J Dermatol,2003,149:977-985. [10] Allen J,Wojnarowska F.Linear IgA disease:the IgA and IgG response to dermal antigens demonstrates a chiefly IgA response to LAD285 and a dermal 180-kDa protein.Br J Dermatol,2003,149:1055-1058. [11] Zillikens D.BP180 as the common autoantigen in blistering diseases with different clinical phenotypes.Keio J Med,2002,51:21-28. [12] Zillikens D,Herzele K,Georgi M,et al.Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801.J Invest Dermatol,1999,113:947-953. [13] Georgi M,Scheckenbach C,Kromminga A,et al.Mapping of epitopes on the BP180 ectodomain targeted by IgA and IgG autoantibodies in patients with the lamina lucida-type of linear IgA disease.Arch Dermatol Res,2001,293:109-114. [14] Zhou S,Ferguson DJ,Allen J,et al.The localization of target antigens and autoantibodies in linear IgA disease is variable:correlation of immunogold electron microscopy and immunoblotting.Br J Dermatol,1998,139:591-597. [15] Lin MS,Fu CL,Olague-Marchan M,et al.Autoimmune responses in patients with linear IgA bullous dermatosis:both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule.Clin Immunol,2002,102:310-319. [16] Caproni M,Rolfo S,Bernacchi E,et al.The role of lymphocytes,granulocytes,mast cells and their related cytokines in lesional skin of linear IgA bullous dermatosis.Br J Dermatol,1999,140:1072-1078. [17] Eguia del Valle A,Aguirre Urizar JM,Martinez Sahuquillo A.Oral manifestations caused by the linear IgA disease.Med Oral,2004,9:39-44. [18] Vodegel RM,de Jong MC,Pas HH,et al.IgA-mediated epidermolysis bullosa acquisita:two cases and review of the literature.J Am Acad Dermatol,2002,47:919-925. [19] Osawa M,Demitsu T,Toda S,et al.A case of mixed bullous disease of epidermolysis bullosa acquisita and linear IgA bullous dermatosis.Dermatology,2005,211:146-148. [20] Farley-Li J,Mancini AJ.Treatment of linear IgA bullous dermatosis of childhood with mycophenolate mofetil.Arch Dermatol,2003,139:1121-1124. [21] Talhari C,Mahnke N,Ruzicka T,et al.Successful treatment of linear IgA disease with mycophenolate mofetil as a corticosteroid sparing agent.Clin Exp Dermatol,2005,30:297-298. 通讯作者: